デフォルト表紙
市場調査レポート
商品コード
1361548

マラリア診断薬市場- 世界の産業規模、シェア、動向、機会、予測、2018-2028年

Malaria Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Technology, By End User, By Region and By Competition

出版日: | 発行: TechSci Research | ページ情報: 英文 73 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.16円

こちらのレポートには、数時間(ご購入金額の10%)分のアナリストへの質問/追加調査サービスが含まれております。

マラリア診断薬市場- 世界の産業規模、シェア、動向、機会、予測、2018-2028年
出版日: 2023年10月03日
発行: TechSci Research
ページ情報: 英文 73 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 目次
概要

世界のマラリア診断薬市場は、予測期間である2024~2028年に急速なペースで成長すると予測されています。

これは、政府資金の増加、研究開発活動(R&D)の増加、世界中でマラリアに苦しむ人々の増加に起因しています。マラリアは、感染した雌のアノフェレス蚊に刺されることでヒトに感染する原虫によって引き起こされる、生命を脅かす病気です。特に熱帯・亜熱帯地域では、蚊の繁殖やマラリア感染に適した条件が整っているため、公衆衛生上の大きな問題となっています。マラリア診断市場は、マラリアの早期かつ正確な診断を保証する重要な役割を担っています。また、マラリア診断薬は、患者が適切な治療を受けていることを確認し、薬剤の過剰使用を防ぎ、重要な疾病監視データを提供し、マラリアの蔓延を抑えるのに役立ちます。

さらに、世界のマラリア診断薬市場は、世界の多くの地域、特にマラリアが公衆衛生の主要な関心事であるサハラ以南のアフリカにおけるマラリアの高い流行によって牽引されています。世界保健機関(WHO)によると、2021年に世界で報告されたマラリアの症例数は約2億4,700万件で、そのうちマラリアによる死亡者数は619万人と推定されています。WHOアフリカ地域は、世界のマラリアの負担のうち不釣り合いに大きな割合を占めています。2021年には、マラリア患者の95%、マラリアによる死亡者の96%がこの地域で発生しています。

  • マラリア診断薬の世界市場:技術別

分子診断検査

迅速診断試験

その他

  • マラリア診断薬の世界市場:エンドユーザー別

病院・診療所

診断センター

在宅医療

その他

  • マラリア診断薬の世界市場:地域別

北米

  • 米国
  • メキシコ
  • カナダ

欧州

  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

アジア太平洋

  • インド
  • 日本
  • 韓国
  • オーストラリア
  • ベトナム
  • インドネシア
  • ミャンマー

南米

  • ブラジル
  • コロンビア

中東&アフリカ

  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • エジプト
  • トルコ
  • ナイジェリア

競合情勢

企業プロファイル:世界のマラリア診断薬市場に参入している主要企業の詳細分析

利用可能なカスタマイズ:

TechSci Researchは、与えられた市場データをもとに、企業固有のニーズに応じたカスタマイズを提供します。レポートでは以下のカスタマイズが可能です:

企業情報

  • 追加市場参入企業(最大5社)の詳細分析とプロファイリング

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 マラリア診断薬の世界市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • 技術別(分子診断検査、迅速診断検査、その他)
    • エンドユーザー別(病院・クリニック、診断センター、在宅医療、その他)
    • 企業別(2022年)
    • 地域別

第6章 北米マラリア診断薬市場の展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • 技術別
    • エンドユーザー別
    • 国別
  • 北米国別分析
    • 米国
    • カナダ
    • メキシコ

第7章 欧州マラリア診断薬市場の展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 技術別
    • エンドユーザー別
    • 国別
  • 欧州国別分析
    • フランス
    • ドイツ
    • 英国
    • イタリア
    • スペイン

第8章 アジア太平洋マラリア診断薬市場展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 技術別
    • エンドユーザー別
    • 国別
  • アジア太平洋:国別分析
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • ベトナム
    • インドネシア
    • ミャンマー

第9章 南米マラリア診断薬市場の展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • 技術別
    • エンドユーザー別
    • 国別
  • 南米::国別分析
    • ブラジル展望
    • コロンビア

第10章 中東・アフリカマラリア診断薬市場の展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 技術別
    • エンドユーザー別
    • 国別
  • MEA:国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • エジプト
    • トルコ
    • ナイジェリア

第11章 市場力学

  • 促進要因
  • 課題

第12章 市場動向と発展

第13章 競合情勢

  • Access Bio., Inc.
  • Abbott Laboratories, Inc.
  • bioMerieux SA
  • altona Diagnostics GmbH
  • Bio-Rad Laboratories, Inc.
  • AdvaCare Pharma
  • Meril Life Sciences Pvt. Ltd.
  • Advy Chemical Pvt. Ltd
  • Premier Medical Corporation Pvt. Ltd.
  • ARKRAY, Inc.

第14章 戦略的提言

目次
Product Code: 15000

Global malaria diagnostics market is anticipated to grow at a rapid pace in the forecast period, 2024-2028. This is attributed to the growing government fundings, increase in research and development activities (R&D), and rise in the number of people suffering from malaria across the world. Malaria is a life-threatening disease caused by the Plasmodium parasite, which is transmitted to humans through the bite of infected female Anopheles mosquitoes. It is a major public health concern, particularly in tropical and subtropical regions, where the conditions are favorable for mosquito breeding and malaria transmission. The Malaria diagnostic market plays a critical role as it ensures the early and accurate diagnosis of malaria. Also, the malaria diagnostics helps to ensure that the patient is receiving the appropriate treatment, preventing the overuse of drugs, providing important disease surveillance data, and reducing the spread of malaria.

Moreover, the global malaria diagnostics market is driven by the high prevalence of malaria in many regions of the world, particularly in sub-Saharan Africa, where malaria is a major public health concern. According to the World Health Organization (WHO), there were approximately 247 million cases of malaria reported worldwide in 2021, out of which 6,19,000 number of malaria deaths were estimated. The WHO African Region carries a disproportionately large amount of the worldwide malaria burden. In 2021, the Region witnessed 95% of malaria cases and 96% of malaria deaths.

In addition to these, there are several other factors which are supporting the growth of the global malaria diagnostics market such as increasing technological advancements, rising demand for diagnostic tools for malaria, increased awareness, and other government initiatives. For instance, in 2022, the Ministry of Health and Family Welfare of India launched a campaign named Jan Abhiyaans with log bhaagidari (people's participation) to enthuse and engage people and communities to ensure that their neighborhoods, premises, and homes for vector control and elimination.

High Prevalence of Malaria

Increasing prevalence of malaria across the world is influenced by various factors, including the presence of the mosquito vector that transmits the parasite, environmental factors that support mosquito breeding, access to effective malaria prevention and control measures, and the level of immunity to the disease in the population. Therefore, to reduce the prevalence of malaria, it is essential to implement effective malaria control strategies, such as early diagnosis and prompt treatment of malaria cases. The rowing prevalence of malaria can influence the demand and uptake of malaria diagnostic tests, which in turn, is expected to bolster the growth of the global malaria diagnostic market in the upcoming years. Rapid diagnostic tests (RDTs) and microscopy are commonly used to diagnose malaria, and accurate diagnosis is essential for effective disease management and control.

In areas with a high prevalence of malaria, the demand for these diagnostic tests can be particularly high, as healthcare providers strive to diagnose and treat as many cases as possible. Therefore, the growing occurrences of malaria across the globe are influencing the growth of the global malaria diagnostic market. According to the World Health Organization's 2021 report, approximately 50% of global malaria fatalities were attributed to just four African nations: Nigeria (31.3%), the Democratic Republic of the Congo (12.6%), United Republic of Tanzania (4.1%), and Niger (3.9%).

Increasing Investments and Technological Advancements

Global malaria diagnostic market has seen significant growth in recent years, and this can largely be attributed to the high prevalence of malaria in many countries. As the demand for malaria diagnostic tests increases, companies that produce these tests are expanding their operations and investing in research and development to improve the accuracy, sensitivity, and cost-effectiveness of their products. The high burden of malaria in many countries has driven the growth of the malaria diagnostic market. This high prevalence of malaria has led to a significant demand for malaria diagnostic tests, including rapid diagnostic tests (RDTs) and microscopy. In response to this demand, many companies have invested in the production and distribution of malaria diagnostic tests. These tests have become increasingly accessible in many countries, including those with a high burden of malaria. Companies producing malaria diagnostic tests have also focused on improving the accuracy, sensitivity, and cost-effectiveness of their products, making them more attractive to healthcare providers in resource-limited settings. Also, the growth of the global malaria diagnostic market has also been driven by technological advancements in diagnostic technologies. For example, there has been a significant shift towards the use of molecular diagnostic tests, such as polymerase chain reaction (PCR) tests, which can provide more accurate and sensitive results than traditional microscopy and RDTs. These new technologies are improving the accuracy of malaria diagnosis and helping to reduce the burden of the disease in many countries. In addition, another promising development in the field of malaria diagnostics is the use of artificial intelligence (AI) and machine learning (ML) algorithms to improve the accuracy and speed of malaria diagnosis. These tools can analyze large datasets of malaria cases to identify patterns and predict disease outbreaks, helping to inform public health interventions. Also, increase in research and development activities are done in order to develop new malaria diagnostic tools, such as biosensors and nanotechnology-based tests, which have the potential to improve the speed, sensitivity, and specificity of malaria diagnosis. These advancements as well as the introduction of novel malaria diagnostic techniques are expected to drive the growth of the global malaria diagnostic market in the forthcoming years.

Increasing Government Funding

Increasing government funding is another important factor driving the growth of the global malaria diagnostics market. Many governments, particularly in malaria-endemic countries, are investing in malaria control and elimination programs. This includes funding for the development and distribution of diagnostic tests, which has helped to drive growth in the malaria diagnostics market. Government funding has been instrumental in expanding access to malaria diagnostics, particularly in low-resource settings where malaria is most prevalent. Governments are often key stakeholders in the fight against malaria, and they play a critical role in financing and implementing malaria control programs. For example, the Global Fund to Fight AIDS, Tuberculosis and Malaria, which is a partnership between governments, civil society, and the private sector, has played a significant role in funding malaria control programs in many countries. The funding provided by governments has been used to develop new diagnostic technologies, improve the distribution of existing tests, and increase access to diagnostics in remote and low-resource settings. For example, some governments have invested in the development of new, more accurate and cost-effective rapid diagnostic tests (RDTs), which are particularly useful in resource-limited settings where traditional diagnostic methods may not be feasible. In addition, government funding has helped to support public health campaigns and education programs that emphasize the importance of malaria diagnosis and treatment. These programs can help to raise awareness about the benefits of early diagnosis and treatment, which can help to reduce the burden of malaria and improve health outcomes.

Market Segmentation:

Global malaria diagnostics market is segmented into technology, end user, company, and region. Based on technology, the global malaria diagnostics market is segmented into molecular diagnostics tests, rapid diagnostic tests, and others. Based on end user, the global Malaria diagnostics market is divided into hospitals & clinics, diagnostic centers, home care, and others. In terms of region, the Middle East & Africa dominated the global malaria diagnostics market on account of the increasing research & development activities along with an increase in the number of people suffering from malaria.

Market Players

Access Bio., Inc., Abbott Laboratories, Inc., bioMerieux SA, altona Diagnostics GmbH, Bio-Rad Laboratories, Inc., AdvaCare Pharma, Meril Life Sciences Pvt. Ltd., Advy Chemical Pvt. Ltd, Premier Medical Corporation Pvt. Ltd., and ARKRAY, Inc. are some of the major leading players of the global malaria diagnostics market.

Report Scope:

In this report, global malaria diagnostics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global Malaria Diagnostics Market, By Technology:

Molecular Diagnostic Tests

Rapid Diagnostic Test

Others

  • Global Malaria Diagnostics Market, By End User:

Hospitals & Clinics

Diagnostic Centers

Home Care

Others

  • Global Malaria Diagnostics Market, By Region:

North America

  • United States
  • Mexico
  • Canada

Europe

  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain

Asia-Pacific

  • India
  • Japan
  • South Korea
  • Australia
  • Vietnam
  • Indonesia
  • Myanmar

South America

  • Brazil
  • Colombia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Turkey
  • Nigeria

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global malaria diagnostics market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Malaria Diagnostics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Technology (Molecular Diagnostics Tests, Rapid Diagnostic Tests, and Others)
    • 5.2.2. By End User (Hospitals & Clinics, Diagnostic Centers, Home Care, and Others)
    • 5.2.3. By Company (2022)
    • 5.2.4. By Region

6. North America Malaria Diagnostics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Technology
    • 6.2.2. By End User
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Malaria Diagnostics Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Technology
        • 6.3.1.2.2. By End User
    • 6.3.2. Canada Malaria Diagnostics Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Technology
        • 6.3.2.2.2. By End User
    • 6.3.3. Mexico Malaria Diagnostics Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Technology
        • 6.3.3.2.2. By End User

7. Europe Malaria Diagnostics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Technology
    • 7.2.2. By End User
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Malaria Diagnostics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Technology
        • 7.3.1.2.2. By End User
    • 7.3.2. Germany Malaria Diagnostics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Technology
        • 7.3.2.2.2. By End User
    • 7.3.3. United Kingdom Malaria Diagnostics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Technology
        • 7.3.3.2.2. By End User
    • 7.3.4. Italy Malaria Diagnostics Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Technology
        • 7.3.4.2.2. By End User
    • 7.3.5. Spain Malaria Diagnostics Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Technology
        • 7.3.5.2.2. By End User

8. Asia-Pacific Malaria Diagnostics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Technology
    • 8.2.2. By End User
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. India Malaria Diagnostics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Technology
        • 8.3.1.2.2. By End User
    • 8.3.2. Japan Malaria Diagnostics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Technology
        • 8.3.2.2.2. By End User
    • 8.3.3. South Korea Malaria Diagnostics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Technology
        • 8.3.3.2.2. By End User
    • 8.3.4. Australia Malaria Diagnostics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Technology
        • 8.3.4.2.2. By End User
    • 8.3.5. Vietnam Malaria Diagnostics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Technology
        • 8.3.5.2.2. By End User
    • 8.3.6. Indonesia Malaria Diagnostics Market Outlook
      • 8.3.6.1. Market Size & Forecast
        • 8.3.6.1.1. By Value
      • 8.3.6.2. Market Share & Forecast
        • 8.3.6.2.1. By Technology
        • 8.3.6.2.2. By End User
    • 8.3.7. Myanmar Malaria Diagnostics Market Outlook
      • 8.3.7.1. Market Size & Forecast
        • 8.3.7.1.1. By Value
      • 8.3.7.2. Market Share & Forecast
        • 8.3.7.2.1. By Technology
        • 8.3.7.2.2. By End User

9. South America Malaria Diagnostics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Technology
    • 9.2.2. By End User
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Malaria Diagnostics Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Technology
        • 9.3.1.2.2. By End User
    • 9.3.2. Colombia Malaria Diagnostics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Technology
        • 9.3.2.2.2. By End User

10. Middle East & Africa Malaria Diagnostics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Technology
    • 10.2.2. By End User
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Malaria Diagnostics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Technology
        • 10.3.1.2.2. By End User
    • 10.3.2. Saudi Arabia Malaria Diagnostics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Technology
        • 10.3.2.2.2. By End User
    • 10.3.3. UAE Malaria Diagnostics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Technology
        • 10.3.3.2.2. By End User
    • 10.3.4. Egypt Malaria Diagnostics Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Technology
        • 10.3.4.2.2. By End User
    • 10.3.5. Turkey Malaria Diagnostics Market Outlook
      • 10.3.5.1. Market Size & Forecast
        • 10.3.5.1.1. By Value
      • 10.3.5.2. Market Share & Forecast
        • 10.3.5.2.1. By Technology
        • 10.3.5.2.2. By End User
    • 10.3.6. Nigeria Malaria Diagnostics Market Outlook
      • 10.3.6.1. Market Size & Forecast
        • 10.3.6.1.1. By Value
      • 10.3.6.2. Market Share & Forecast
        • 10.3.6.2.1. By Technology
        • 10.3.6.2.2. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

13. Competitive Landscape

  • 13.1. Access Bio., Inc.
  • 13.2. Abbott Laboratories, Inc.
  • 13.3. bioMerieux SA
  • 13.4. altona Diagnostics GmbH
  • 13.5. Bio-Rad Laboratories, Inc.
  • 13.6. AdvaCare Pharma
  • 13.7. Meril Life Sciences Pvt. Ltd.
  • 13.8. Advy Chemical Pvt. Ltd
  • 13.9. Premier Medical Corporation Pvt. Ltd.
  • 13.10. ARKRAY, Inc.

14. Strategic Recommendations